Evidence map›Paper›PMID 29625013›Full record

ArticleAmerican journal of respiratory cell and molecular biology2018

Successful Establishment of Primary Type II Alveolar Epithelium with 3D Organotypic Coculture.

Jennifer M S Sucre, Christopher S Jetter, Holli Loomans, Janice Williams, Erin J Plosa, John T Benjamin, Lisa R Young, Jonathan A Kropski, Carla L Calvi, Seunghyi Kook and 7 more

Abstract read
In one paragraph

Article in American journal of respiratory cell and molecular biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 2 countries.

Jennifer M S Sucre1 Mildred Stahlman Division of Neonatology, Department of Pediatrics.ORCID 0000-0002-6613-1439
Christopher S Jetter1 Mildred Stahlman Division of Neonatology, Department of Pediatrics.
Holli Loomans2 Program in Cancer Biology.
Janice Williams3 Cell Imaging Shared Resource, and.
Erin J Plosa1 Mildred Stahlman Division of Neonatology, Department of Pediatrics.
John T Benjamin1 Mildred Stahlman Division of Neonatology, Department of Pediatrics.
Lisa R Young5 Department of Cell and Developmental Biology, Vanderbilt University, Nashville, Tennessee.
Jonathan A Kropski4 Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine.
Carla L Calvi4 Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine.
Seunghyi Kook1 Mildred Stahlman Division of Neonatology, Department of Pediatrics.
Ping Wang1 Mildred Stahlman Division of Neonatology, Department of Pediatrics.
Linda Gleaves4 Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine.
Adel Eskaros2 Program in Cancer Biology.
Laura Goetzl8 Department of Obstetrics and Gynecology, Temple University, Philadelphia, Pennsylvania; and.
Timothy S Blackwell5 Department of Cell and Developmental Biology, Vanderbilt University, Nashville, Tennessee.
Susan H Guttentag1 Mildred Stahlman Division of Neonatology, Department of Pediatrics.ORCID 0000-0003-4420-5879
Andries Zijlstra2 Program in Cancer Biology.
Centre for Cancer Biology · AUPulmonary and Allergy Associates · USVanderbilt University · USTemple University · US

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MATTHEW J TYSKA · 1995 to 2026
$172.8M
Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2002 to 2026
$29.9M
Vanderbilt Diabetes Research CenterP30DK020593 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI OWEN P MCGUINNESS · 2012 to 2026
$29.3M
Mechanisms of Familial Pulmonary FibrosisP01HL092870 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BLACKWELL, TIMOTHY S. · 2010 to 2020
$21.6M
Data Coordinating Center for the Prematurity and Respiratory Outcomes ProgramU01HL101794 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI SCHMIDT, BARBARA · 2010 to 2014
$10.3M
Interdisciplinary Training Program in Lung ResearchT32HL094296 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Ray Stokes Peebles · 2008 to 2026
$6.3M
Pathogenesis, Targeted Therapeutics, and New Vaccines for Childhood DiseaseK12HD087023 · NICHD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Michael R. DeBaun, Juan C Salazar · 2016 to 2026
$4.1M
Mechanisms of Pulmonary Fibrosis in Hermansky-Pudlak SyndromeR01HL119503 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI YOUNG, LISA R. · 2013 to 2021
$3.6M
Epithelial-Fibroblast Interactions in Lung FibrosisR01HL085317 · NHLBI · VANDERBILT UNIVERSITY · PI BLACKWELL, TIMOTHY S. · 2007 to 2015
$3.5M
MOLECULAR SIGNALS FOR TRAFFICKING SURFACTANT PROTEIN BR01HL059959 · NHLBI · CHILDREN'S HOSP OF PHILADELPHIA · PI GUTTENTAG, SUSAN H. · 1998 to 2011
$3.4M
High-throughput palmitoyl-proteomics profiling of extracellular vesicles for identification of biomarkers for early detection of clinically significant prostate cancerR01CA218526 · NCI · CEDARS-SINAI MEDICAL CENTER · PI DI VIZIO, DOLORES, HURLEY, PAULA JILL · 2017 to 2021
$2.0M
Lamellar Body Biogenesis in Health and DiseaseR01GM108807 · NIGMS · CHILDREN'S HOSP OF PHILADELPHIA · PI GUTTENTAG, SUSAN H., MARKS, MICHAEL S · 2014 to 2017
$1.5M
NCI NIH HHS P30 CA068485NCI NIH HHS R01 CA218526NHLBI NIH HHS K08 HL127102NHLBI NIH HHS K08 HL130595NHLBI NIH HHS P01 HL092870NHLBI NIH HHS R01 HL059959NHLBI NIH HHS R01 HL085317NHLBI NIH HHS R01 HL119503NHLBI NIH HHS R38 HL143619NHLBI NIH HHS T32 HL094296NHLBI NIH HHS U01 HL101794NICHD NIH HHS K12 HD087023NIDCR NIH HHS F31 DE025477NIDDK NIH HHS P30 DK020593NIDDK NIH HHS P30 DK058404NIGMS NIH HHS R01 GM108807
6 · The paper itself

Abstract

Alveolar type II (AT2) epithelial cells are uniquely specialized to produce surfactant in the lung and act as progenitor cells in the process of repair after lung injury. AT2 cell injury has been implicated in several lung diseases, including idiopathic pulmonary fibrosis and bronchopulmonary dysplasia. The inability to maintain primary AT2 cells in culture has been a significant barrier in the investigation of pulmonary biology. We have addressed this knowledge gap by developing a three-dimensional (3D) organotypic coculture using primary human fetal AT2 cells and pulmonary fibroblasts. Grown on top of matrix-embedded fibroblasts, the primary human AT2 cells establish a monolayer and have direct contact with the underlying pulmonary fibroblasts. Unlike conventional two-dimensional (2D) culture, the structural and functional phenotype of the AT2 cells in our 3D organotypic culture was preserved over 7 days of culture, as evidenced by the presence of lamellar bodies and by production of surfactant proteins B and C. Importantly, the AT2 cells in 3D cocultures maintained the ability to replicate, with approximately 60% of AT2 cells staining positive for the proliferation marker Ki67, whereas no such proliferation is evident in 2D cultures of the same primary AT2 cells. This organotypic culture system enables interrogation of AT2 epithelial biology by providing a reductionist in vitro model in which to investigate the response of AT2 epithelial cells and AT2 cell-fibroblast interactions during lung injury and repair.

Indexed as

Cell CommunicationCells, CulturedCoculture TechniquesEpithelial CellsFibroblastsHumansLungLung InjuryPhenotypealveolar type II cellepithelial–mesenchymal interactionslung modelorganotypic coculture

Identifiers

PMID29625013
PMCPMC6096337
OpenAlexW2796352133

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.